InterCure Ltd. INCR
5.21
(0.05)
(0.95%)
as of 25 Sep
- Market cap
- $62.3M
- P/E
- 9.8×
Follow INCR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 50.92 | 50.92 | 205.98 | 11.09 | 12.31 | 15.01 | 8.59 |
P/S ratio |
— | — | — | 0.00 | 0.00 | 21.03 | 1.34 | 2.47 | 3.01 | 1.73 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 144.34 | 17.14 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (146.18) | 59.92 | 793.36 | 12.49 | (19.98) | (24.36) | 60.80 |
P/B ratio |
— | — | — | 2.73 | 2.05 | 10.12 | 1.04 | 2.06 | 2.92 | 1.72 |
Price to Tangible BV |
— | — | — | 12.55 | 6.66 | 23.86 | 2.28 | 4.45 | 5.67 | 3.57 |
EV/Sales |
— | — | — | 0.00 | 0.00 | 20.52 | 1.04 | 2.45 | 3.12 | 1.87 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 111.58 | 6.70 | 27.06 | 34.52 | 20.70 |
EV/Operating CF |
— | — | — | 0.00 | 0.00 | 140.88 | 8.14 | (1,150.09) | (1,466.92) | 77.16 |
EV/FCF |
— | — | — | 0.00 | 0.00 | 140.88 | 13.24 | (70.51) | (89.93) | (279.22) |
Quick Ratio |
0.89 | 0.76 | 0.31 | 1.51 | 1.80 | 1.39 | 1.22 | 1.38 | 1.18 | 0.97 |
Current Ratio |
0.89 | 0.76 | 0.31 | 1.86 | 2.57 | 1.74 | 1.62 | 1.85 | 1.73 | 1.48 |
Net Debt/EBITDA |
0.00 | (0.43) | (0.93) | 0.13 | (6.30) | (5.13) | (1.97) | 0.29 | (1.10) | (4.07) |
Debt/Assets |
8.63% | 0.00% | 35.57% | 6.04% | 2.05% | 5.11% | 12.93% | 13.07% | 17.99% | 13.03% |
Debt/Equity |
0.10 | 0.14 | 0.65 | 0.07 | 0.02 | 0.08 | 0.24 | 0.23 | 0.35 | 0.23 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.06 | 0.22 | 0.45 | 0.48 | 0.39 | 0.32 | 0.39 |
Operating CF/Net income |
(4.41) | 0.18 | 0.12 | 1.96 | (0.21) | 5.33 | 1.14 | 0.87 | 0.99 | (0.47) |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | 0.00 | (1.90) | (1.69) | (0.20) | (0.31) | (0.21) |
Interest Coverage |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.13% | (25.66%) | (60.96%) | (4.30%) | (14.54%) | 1.28% | 8.98% | (12.04%) | (15.82%) | (9.32%) | |
| 0.98% | (43.41%) | (71.26%) | (3.74%) | (12.66%) | 0.92% | 5.36% | (6.74%) | (8.73%) | (5.10%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.37% | 7.94% | (5.79%) | (9.23%) | (3.90%) |
Return on Tangible Assets |
(69.53%) | 696.74% | 114.13% | (11.39%) | (37.14%) | 2.05% | 15.04% | (21.34%) | (25.08%) | (17.40%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 270.13 | 86.19 | 81.71 | 122.01 | 206.73 | 277.51 | 216.12 |
Research and Development Expense of Revenue |
— | — | — | 19.16% | 2.42% | 0.55% | 0.16% | 0.11% | 0.17% | 0.14% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 924.25% | 40.43% | 25.14% | 25.27% | 27.67% | 44.91% | 35.47% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.60 | 0.58 | 0.38 | 0.30 | 0.28 | 0.29 | 0.32 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 0.00% | 2.85% | 2.22% | 0.73% | 0.93% | 0.90% |
Graham Net Nets |
— | — | — | 0.01 | 0.08 | 0.02 | 0.13 | 0.07 | 0.07 | 0.07 |
Graham Number |
— | — | — | 0.00 | 0.00 | 3.37 | 24.83 | 0.00 | 0.00 | — |
Earnings Yield |
— | — | — | 1.96% | 1.96% | 0.49% | 9.01% | 8.12% | 6.66% | 11.64% |
Free Cash Flow Yield |
— | — | — | 0.00% | 0.00% | 0.69% | 5.84% | (1.40%) | (1.15%) | (0.39%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.11 | 0.80 | 9.10 | 13.20 | 10.60 | 7.23 | 7.30 |
Operating CF per Share |
(0.02) | (0.02) | (0.02) | (0.14) | 0.10 | 1.01 | 1.68 | (1.60) | (1.97) | 0.46 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.56) | (0.65) | (0.08) | (0.14) | (0.10) |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.02) | (0.14) | 0.10 | 0.44 | 1.04 | (1.68) | (2.11) | 0.36 |
Cash per Share |
0.07 | 0.04 | 0.05 | 0.34 | 0.47 | 8.75 | 8.11 | 3.31 | 2.36 | 1.32 |
Shareholders Equity per Share |
0.50 | 0.35 | 0.29 | 3.18 | 3.37 | 18.46 | 17.13 | 13.62 | 11.71 | 10.71 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.50 | 0.35 | 0.29 | 3.18 | 3.37 | 18.46 | 17.13 | 13.62 | 11.71 | 10.71 |
Free Cash Flow |
(0.30) | (0.27) | (0.40) | (3.34) | 2.43 | 3.40 | 9.39 | (15.27) | (19.39) | 3.86 |
Working Capital |
(0.10) | (0.23) | (3.01) | 5.66 | 14.57 | 44.13 | 58.04 | 52.40 | 44.60 | 29.74 |
Capital Expenditures |
0.00 | — | (0.02) | (8.13) | (6.49) | (4.34) | (5.88) | (0.70) | (1.30) | (1.03) |
Net Current Asset Value |
(0.10) | (0.23) | (3.01) | 4.68 | 13.24 | 33.74 | 21.15 | 24.24 | 7.27 | 6.55 |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 8.25 | 28.01 | 35.73 | 21.43 |
Capex to Sales |
— | — | — | 0.00 | 0.00 | 0.06 | 0.05 | 0.01 | 0.02 | 0.01 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (66.02%) | (57.25%) | 2.07% | 11.16% | (17.41%) | (27.64%) | (13.22%) |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 10.67 | 28.28 | 34.48 | 19.74 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 1.03 | 0.12 | 0.03 | 0.06 | 0.09 | 0.11 | 0.14 | 0.15 | 0.17 |
Cash ROIC |
(3.95%) | (3.68%) | (4.35%) | (14.55%) | (14.29%) | (8.64%) | (5.81%) | (22.52%) | (28.00%) | (16.07%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 2.29 | 6.05 | 6.84 | 4.30 | 2.04 | 1.26 | 1.62 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 3.02 | 3.05 | 3.25 | 2.56 | 2.31 | 2.75 | 3.38 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.51 | 2.51 | 2.98 | 2.50 | 2.05 | 1.85 | 2.11 |
Average Days of Payables |
— | 0.00 | 8,285.50 | 232.15 | 192.04 | 174.16 | 186.55 | 114.19 | 131.59 | 104.93 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 286.58 | 232.43 | 183.36 | 187.19 | 154.74 | 212.70 | 166.40 |
Average Receivables |
0.01 | 0.01 | 0.18 | 1.13 | 3.35 | 10.23 | 27.85 | 47.38 | 52.56 | 48.43 |
Average Payables |
— | — | 0.74 | 0.74 | 3.61 | 12.88 | 28.76 | 29.44 | 21.13 | 20.37 |
Average Inventory |
— | — | — | 4.39 | 4.39 | 14.02 | 29.35 | 33.28 | 31.37 | 32.63 |
Average Assets |
7.06 | 3.61 | 4.79 | 45.57 | 91.61 | 157.03 | 248.95 | 249.57 | 209.85 | 203.33 |
Average Common Equity |
6.11 | 6.11 | 5.60 | 39.61 | 79.75 | 113.82 | 148.76 | 139.77 | 115.79 | 111.30 |
Columns are period end dates